This company seems to have been delisted
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
Reason: Rebranded as Artivion (AORT)
Source: https://www.prnewswire.com/news-releases/cryolife-announces-corporate-rebranding-and-changes-name-to-artivion-301462581.html
CryoLife
CRY
$17.88
Share price
1.42%
Change (1 day)
-21.51%
Change (1 year)
Categories
Revenue for CryoLife (CRY)
Revenue in 2021 (TTM): $0.29 Billion USD
According to CryoLife's latest financial reports the company's current revenue is $0.29 Billion USD. In 2020 the company made a revenue of $0.25 Billion USD a decrease over the revenue in the year 2019 that were of $0.27 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for CryoLife from 2001 to 2021
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $0.29 B | 18.01% |
| 2020 | $0.25 B | -8.32% |
| 2019 | $0.27 B | 5.09% |
| 2018 | $0.26 B | 38.55% |
| 2017 | $0.18 B | 5.17% |
| 2016 | $0.18 B | 23.63% |
| 2015 | $0.14 B | 0.87% |
| 2014 | $0.14 B | 2.81% |
| 2013 | $0.14 B | 7.32% |
| 2012 | $0.13 B | 9.59% |
| 2011 | $0.11 B | 2.56% |
| 2010 | $0.11 B | 4.12% |
| 2009 | $0.11 B | 6.64% |
| 2008 | $0.10 B | 10.87% |
| 2007 | $94.76 M | 16.54% |
| 2006 | $81.31 M | 17.36% |
| 2005 | $69.28 M | 11.06% |
| 2004 | $62.38 M | 4.79% |
| 2003 | $59.53 M | -23.48% |
| 2002 | $77.79 M | -11.26% |
| 2001 | $87.67 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $11.88 B | 3,878.44% | 🇺🇸 USA |
 Edwards Lifesciences EW | $5.53 B | 1,753.46% | 🇺🇸 USA |
 Medtronic MDT | $33.53 B | 11,122.54% | 🇮🇪 Ireland |
 Stryker Corporation SYK | $23.21 B | 7,669.48% | 🇺🇸 USA |
 Integra LifeSciences IART | $1.62 B | 443.54% | 🇺🇸 USA |
 Boston Scientific BSX | $17.55 B | 5,773.79% | 🇺🇸 USA |
 Teleflex TFX | $3.01 B | 907.29% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $89.33 B | 29,792.98% | 🇺🇸 USA |